In order to further validate the cellular function of YUKA1, we tested YUKA1 in ZR-75-1 breast cancer cells, a cell line with KDM5A amplification and in which RNAi-mediated knockdown of KDM5A resulted in decreased cell proliferation [15]. This evidence concerns the gene KDM5A and breast cancer.